Supply Of Rituximab Drug, Subcutaneous Injection Solution For 1,400 Mg/11.7 Ml And/Or 1,600 Mg/13.4 Ml In Implementation Of Government Decision No. 1416 Of 26.11.2018 Of The Russian Federation On The Procedure For The Provision Of Drugs To Persons Suffering From Hemophilia, Mucocicidosis, Hypophysary Nasism, Goshe Disease, Malignant Neoplasms Of Lymphoid, Blood And Related Tissues, Dispersed Sclerosis, Hemolitic Uremic Syndrome, Juvenile Arthritis With A Systemic Start, Mucopolisacharidosis I, Ii And Vi Types, Aplastic Anemia Of Undefined, Inherited Deficiency Factors Ii (Fibrinogen), Vii (Labyl), X (Stewarta-Prover), Persons After Organ Transplantation And (Or) Tissue, As Well As The Recognition Of Certain Acts Of The Government Of The Russian Federation As Having Lost Force" (EXPIRED)

Teklif Çağrısı